r DBVT Stock Quote - DBV Technologies SA Sponsored ADR Stock Price Today
TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds

DBV Technologies SA Sponsored ADR
(NASDAQ : DBVT)

( )
DBVT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.00%79.541.2%$617.34m
AMGNAmgen Inc.
0.00%177.961.2%$579.57m
GILDGilead Sciences, Inc.
0.00%67.530.9%$547.73m
BIIBBiogen Inc.
0.00%284.411.2%$489.40m
REGNRegeneron Pharmaceuticals, Inc.
0.00%294.612.6%$305.85m
ILMNIllumina, Inc.
0.00%270.833.5%$228.12m
VRTXVertex Pharmaceuticals Incorporated
0.00%156.971.9%$223.27m
ALXNAlexion Pharmaceuticals, Inc.
0.00%117.142.0%$216.01m
AAgilent Technologies, Inc.
0.00%64.131.5%$205.67m
NKTRNektar Therapeutics
0.00%80.586.0%$188.74m
INCYIncyte Corporation
0.00%66.672.5%$152.87m
SRPTSarepta Therapeutics, Inc.
0.00%89.9916.6%$124.68m
BMRNBioMarin Pharmaceutical Inc.
0.00%88.284.4%$120.50m
EXASExact Sciences Corporation
0.00%52.8525.5%$108.34m
BLUEBluebird Bio, Inc.
0.00%187.0015.7%$96.24m

Company Profile

DBV Technologies SA is a clinical-stage biopharmaceutical company, which deals with conducting of research and development of epicutaneous immunotherapy products. It focuses on developing a novel technology platform called Viaskin, which is an electrostatic patch that offers a convenient, self-administered, non-invasive immunotherapy to patients. The company has designed two products candidates: Viaskin Peanut and Viaskin Milk. DBV Technologies was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.